Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour - 21/08/11
Doi : 10.1016/S1470-2045(05)70321-1
Florian Grimpen, MD a, Desmond Yip, DrFRACP a, ⁎ 
, Grant McArthur, FRACP c, Paul Waring, MD d, David Goldstein, FRACP e, Maurice Loughrey, MRCPath d, Victoria Beshay, PhD d, Guan Chong, FRACS b
, Grant McArthur, FRACP c, Paul Waring, MD d, David Goldstein, FRACP e, Maurice Loughrey, MRCPath d, Victoria Beshay, PhD d, Guan Chong, FRACS b a Medical Oncology Unit, Canberra Hospital, Garran, Australia
b Department of Surgery, Canberra Hospital, Garran, Australia
c Division of Clinical Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
d Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia
e Institute of Oncology, Prince of Wales Hospital, Randwick, Australia
* Correspondence to: Dr Desmond Yip, Medical Oncology Unit, Canberra Hospital, PO Box 11, Woden Australian Capital Territory 2606, Australia
© 2005
Elsevier Ltd. Tous droits réservés.
Vol 6 - N° 9
P. 724-727 - septembre 2005 Retour au numéro
Article précédent
- Does early stem-cell transplantation have a role in chronic myeloid leukaemia?
- Alois Gratwohl, Gianantonio Rosti, Michele Baccarani
- Concomitant eosinophilia, fasciitis, and mycosis fungoides-like reaction with antinuclear autoantibodies in chronic myeloid leukaemia: role of a T-cell clone induced by imatinib
- Fabrice Jardin, Philippe Courville, Pascal Lenain, Sophie Pouplin, Nathalie Contentin, Sophie Lehembre, Annie Laquerriere, Jean-François Clément, Hervé Tilly, Bernard Lenormand
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?